FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine and is a method for assessing the severity of sepsis, including the preparation of blood samples of patients with sepsis for fluorescent in situ hybridization with the subsequent detection of bacteria in blood samples using fluorescent microscopy, characterized in that determine the amount of bacteria adhered on the surface of erythrocytes and placed intraerythrocytically and calculate the integral indicator by the formula: II = 1.527 + 0.333 × X1 - 1.116 × X2 - 0.137 × X3 + 0.033 × X4 + 0.061 × X5 - 0.184 × X6 + 3.242 × X7 + 0.71× X8 + 0.888 × X9 + 0.336 × X10, where: X1 - number of adhered bacteria on the surface of erythrocytes in a patient's blood sample, treated with the Oligo1 probe; X2 - number of adhered bacteria on the surface of erythrocytes in a patient's blood sample, treated with the Oligo2 probe; X3 - number of adhered bacteria on the surface of erythrocytes in a patient's blood sample, treated with the Oligo3 probe; X4 - number of adhered bacteria on the surface of erythrocytes in a patient's blood sample, treated with the Oligo4 probe; X5 - number of adhered bacteria on the surface of erythrocytes in a patient's blood sample, treated with the Oligo5 probe; X6 - number of intraerythrocytically placed bacteria in the patient's blood sample treated with the Oligo1 probe; X7 - number of intraerythrocytically placed bacteria in the patient's blood sample treated with the Oligo2 probe; X8 - number of intraerythrocytically placed bacteria in the patient's blood sample treated with the Oligo3 probe; X9 - number of intraerythrocytically placed bacteria in the patient's blood sample treated with the Oligo4 probe; X10 - number of intraerythrocytically placed bacteria in the patient's blood sample treated with the Oligo5 probe, however, when a value of the integral indicator is less than 2.5, the severity of sepsis is considered light, with a value from 2.5 to 5.6 - moderate, and with a value greater than 5.6 - heavy.
EFFECT: method allows to increase the accuracy of early diagnosis of sepsis and assess the severity of the disease.
1 cl, 2 dwg, 4 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSESSING THE RISK OF UNFAVOURABLE OUTCOME OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | 2021 |
|
RU2790520C1 |
DIAGNOSTIC TECHNIQUE FOR ACUTE PYELONEPHRITIS STAGE | 2019 |
|
RU2716713C1 |
METHOD FOR DETERMINING ETIOLOGY OF CHRONIC HEART FAILURE | 2020 |
|
RU2748529C1 |
METHOD OF PREDICTION OF POSTOPERATIVE CARDIAC ISCHEMIC COMPLICATIONS IN A PATIENT WITH LUNG CANCER | 2022 |
|
RU2798781C1 |
METHOD OF PREDICTING RISK OF DEVELOPMENT OF ESSENTIAL ARTERIAL HYPERTENSION IN YOUNG MEN WITH HAEMOCOAGULATION DISORDERS | 2014 |
|
RU2550722C1 |
METHOD OF PREDICTING COURSE OF ESSENTIAL ARTERIAL HYPERTENSION IN TEENAGERS | 2009 |
|
RU2408253C1 |
METHOD FOR PREDICTING LIKELIHOOD OF COMPLICATIONS IN EARLY POSTOPERATIVE PERIOD IN PATIENTS WHO HAVE UNDERGONE GASTRECTOMY FOR GASTRIC CANCER | 2023 |
|
RU2804995C1 |
METHOD FOR PREDICTION OF ESSENTIAL ARTERIAL HYPERTENSION DEVELOPMENT IN CHILDHOOD | 2017 |
|
RU2641378C1 |
METHOD OF PREDICTING RISK OF REPRODUCTIVE DISTURBANCE DEVELOPMENT IN BOYS OF JUVENILE AGE | 2009 |
|
RU2393757C1 |
METHOD OF PREDICTING A RISK OF COMPLICATIONS OF UNIPOLAR TRANSURETHRAL ENUCLEATION OF BENIGN PROSTATIC HYPERPLASIA | 2018 |
|
RU2698623C1 |
Authors
Dates
2019-04-16—Published
2018-03-05—Filed